FR2524M - Composition perfusable stable pour le traitement de la tuberculose. - Google Patents

Composition perfusable stable pour le traitement de la tuberculose.

Info

Publication number
FR2524M
FR2524M FR920945A FR920945A FR2524M FR 2524 M FR2524 M FR 2524M FR 920945 A FR920945 A FR 920945A FR 920945 A FR920945 A FR 920945A FR 2524 M FR2524 M FR 2524M
Authority
FR
France
Prior art keywords
tuberculosis
stable
treatment
infusable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR920945A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paul Metadier SA Lab
Original Assignee
Paul Metadier SA Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Metadier SA Lab filed Critical Paul Metadier SA Lab
Priority to FR920945A priority Critical patent/FR2524M/fr
Priority to SE14269/63A priority patent/SE322016B/xx
Priority to CH1583363A priority patent/CH422787A/fr
Priority to US333622A priority patent/US3297528A/en
Priority to GB1220/64A priority patent/GB1018672A/en
Application granted granted Critical
Publication of FR2524M publication Critical patent/FR2524M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/83Thioacids; Thioesters; Thioamides; Thioimides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR920945A 1963-01-10 1963-01-10 Composition perfusable stable pour le traitement de la tuberculose. Expired FR2524M (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR920945A FR2524M (fr) 1963-01-10 1963-01-10 Composition perfusable stable pour le traitement de la tuberculose.
SE14269/63A SE322016B (fr) 1963-01-10 1963-12-19
CH1583363A CH422787A (fr) 1963-01-10 1963-12-23 Procédé de préparation d'un sel complexe d'éthionamide en solution
US333622A US3297528A (en) 1963-01-10 1963-12-26 Stable perfusable composition for the treatment of tuberculosis
GB1220/64A GB1018672A (en) 1963-01-10 1964-01-10 Solution for the treatment of tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR920945A FR2524M (fr) 1963-01-10 1963-01-10 Composition perfusable stable pour le traitement de la tuberculose.

Publications (1)

Publication Number Publication Date
FR2524M true FR2524M (fr) 1964-05-11

Family

ID=8794388

Family Applications (1)

Application Number Title Priority Date Filing Date
FR920945A Expired FR2524M (fr) 1963-01-10 1963-01-10 Composition perfusable stable pour le traitement de la tuberculose.

Country Status (5)

Country Link
US (1) US3297528A (fr)
CH (1) CH422787A (fr)
FR (1) FR2524M (fr)
GB (1) GB1018672A (fr)
SE (1) SE322016B (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1306607A (fr) * 1959-11-12 1962-10-19 Procédé de solubilisation de produits chimiques

Also Published As

Publication number Publication date
SE322016B (fr) 1970-03-23
CH422787A (fr) 1966-10-31
US3297528A (en) 1967-01-10
GB1018672A (en) 1966-01-26

Similar Documents

Publication Publication Date Title
FR1502803A (fr) Nouvelles compositions pour le traitement des chevelures endommagées
FR1593M (fr) Compositions pour le traitement de l'acne.
CH550853A (fr) Composition pour le traitement des textiles.
OA00339A (fr) Composition pour le traitement des cheveux.
NL6403449A (nl) Concepthouder of dergelijke
BE632037A (fr) Nouveau composé utilisable pour le traitement des manifestations inflammatoires ou douloureuses.
FR2489M (fr) Médicament pour le traitement de la dysenterie amibienne.
CH473235A (fr) Composition pour le traitement des surfaces métalliques
FR2524M (fr) Composition perfusable stable pour le traitement de la tuberculose.
FR1296478A (fr) Composition pour lubrification
CH404231A (de) Mikroskopobjektiv
BE650350A (fr) Composition pour le traitement de la goutte
FR3277M (fr) Composition pour le traitement de dégénérescences métaboliques.
FR1367854A (fr) Composition pour le traitement de la chevelure
FR3880M (fr) Nouveaux médicaments, en particulier pour le traitement de la tuberculose.
FR1319137A (fr) Table roulante pour usages domestiques
FR2849M (fr) Composition pour soins dentaires.
CH425856A (fr) Support de voie ferrée
FR1338926A (fr) Four pour le traitement de feuillards
FR1319251A (fr) étui notamment pour feuillets
FR2346M (fr) Médicament pour le traitement des colopathies.
FR2536M (fr) Nouvelle composition pour le traitement de la bilharziose.
FR3881M (fr) Médicament utile notamment pour le traitement de la tuberculose.
FR1366363A (fr) Composition pour le traitement du sol
FR3607M (fr) Composition enzymatique pour le traitement des insuffisances digestives.